Diabetology & Metabolic Syndrome is a premier open-access journal published by BMC, dedicated to advancing the field of endocrinology, diabetes, and metabolic syndrome. Since its inception in 2009, the journal has established itself as a leading platform for original research, reviews, and clinical studies, offering comprehensive insights into the complexities of metabolic diseases. With an impressive ranking in the 2023 category quartiles as Q1 in both Endocrinology, Diabetes and Metabolism, and Internal Medicine, it stands among the top-tier journals in its field. Researchers will appreciate its strong emphasis on disseminating critical findings that influence clinical practices and public health policies. Accessible to a global audience, Diabetology & Metabolic Syndrome's commitment to open access enables the distribution of high-quality research without barriers, fostering an inclusive environment for knowledge sharing. With a strategic focus on the intersection of diabetes management and metabolic disorders, this journal is essential for professionals seeking to stay abreast of the latest developments and contribute to a vital area of healthcare.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, published by Springer, is a leading journal in the field of endocrinology, diabetes, and metabolism, with an impressive Q1 ranking in both categories as of 2023. With an ISSN of 1389-9155 and E-ISSN 1573-2606, this journal serves as a vital resource for researchers, clinicians, and students seeking comprehensive reviews that address the latest advancements and interdisciplinary approaches in the management of endocrine and metabolic disorders. Operating from the Netherlands, it features articles that are rigorously peer-reviewed and is notable for its significant impact factor reflected in its Scopus rankings, placing it in the top percentile of its categories. Although it does not currently offer open access, it provides critical insights applicable to both basic and clinical settings, making it indispensable for those dedicated to enhancing patient outcomes in endocrine health.

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES is a distinguished journal published by GEORG THIEME VERLAG KG, dedicated to advancing research and understanding in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 0947-7349 and an E-ISSN of 1439-3646, this journal serves as a critical platform for disseminating high-quality research findings, reviews, and clinical studies from 1983 to 2024. The journal holds an impactful position within its respective categories, notably achieving Q3 in Endocrinology and Diabetes and Metabolism, and Q2 in Internal Medicine as per the 2023 category quartiles. Additionally, it ranks in the 57th and 46th percentiles in the Scopus rankings for Internal Medicine and Endocrinology, Diabetes and Metabolism, respectively. Though not an open-access publication, the journal caters to a global audience of researchers, professionals, and students, facilitating knowledge exchange and fostering collaboration within this vital area of medical science.

Diabetes Metabolic Syndrome and Obesity is a leading open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing research in the fields of diabetes, metabolic syndrome, and obesity. Since its inception in 2008, the journal has aimed to disseminate high-quality, peer-reviewed articles that contribute to our understanding of these prevalent health issues, with a special focus on clinical practices, therapeutic advancements, and epidemiological studies. Boasting a commendable Q2 ranking in both Internal Medicine and Pharmacology for 2023, the journal is placed among the top tier of its category, with a Scopus ranking of #44 out of 167 in Internal Medicine and #124 out of 313 in Pharmacology. This positions the journal in the 73rd and 60th percentiles, respectively, highlighting its significance in the academic community. Researchers and professionals are encouraged to utilize this journal as a valuable resource for access to groundbreaking studies and developments in the treatment and management of diabetes and related metabolic disorders, contributing to global health improvements.

The Journal of Diabetology, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 2010, this Open Access journal has provided researchers and healthcare professionals with a wealth of knowledge through rigorous peer-reviewed articles that cover clinical research, epidemiology, and innovative treatment strategies. With an E-ISSN of 2078-7685 and a commitment to disseminating high-quality scientific work, the journal plays a pivotal role in contributing to the global discourse on diabetes care and prevention. Its dedication to accessibility enhances its impact on both established scholars and emerging researchers seeking to make meaningful contributions in the field. By fostering a collaborative environment, the Journal of Diabetology aims to bridge the gap between research and practical implementation, ultimately improving outcomes for individuals affected by diabetes.

The Journal of Obesity & Metabolic Syndrome, published by the Korean Society for the Study of Obesity, is a premier, open access journal that has been championing research in the realms of endocrinology, diabetes, and metabolism since its inception in 2012. With an ISSN of 2508-6235 and an E-ISSN of 2508-7576, this journal has quickly established itself as a leading publication, currently ranked in the Q1 category within its field and occupying the 46th position out of 244 in Scopus' Medicine category, with an impressive 81st percentile ranking. The journal serves as a vital platform for disseminating high-quality research and innovative findings related to obesity and metabolic disorders, fostering collaboration among researchers, healthcare professionals, and students dedicated to advancing knowledge and treatment strategies. For those interested in contributing or gaining access to cutting-edge research, the journal emphasizes its commitment to open access principles by providing unrestricted access to its content, thereby enhancing the visibility and impact of studies within the global scientific community.

Obesity Research & Clinical Practice is an esteemed journal published by ELSEVIER SCI LTD, focusing on cutting-edge research and clinical practices related to obesity and its multifaceted impact on health and wellness. With an ISSN of 1871-403X and an E-ISSN of 1878-0318, this journal serves as a vital resource for researchers and practitioners in the fields of Endocrinology, Diabetes and Metabolism and Nutrition and Dietetics. Notably, it holds a Q2 ranking in Endocrinology, Diabetes and Metabolism and a prestigious Q1 ranking in Nutrition and Dietetics for 2023, reflecting its influence and quality within the scientific community. The journal features a broad scope of research topics encompassing clinical findings, epidemiological studies, and therapeutic advancements in obesity treatment, aiming to improve health outcomes globally. Submissions are encouraged from diverse disciplines, ensuring a dynamic and multidisciplinary approach to tackling obesity-related challenges. Given its convergence of years from 2007 to 2024, Obesity Research & Clinical Practice stands as a prominent platform for disseminating valuable knowledge, insights, and groundbreaking research in this pressing area of public health.

DIABETES RESEARCH AND CLINICAL PRACTICE, published by Elsevier Ireland Ltd, is a leading peer-reviewed journal in the realms of endocrinology, diabetes, and internal medicine. With a prestigious Q1 classification across several categories, including Endocrinology, Diabetes and Metabolism, and Internal Medicine, this journal is recognized for its impactful contributions to advancing knowledge and clinical practice in diabetes care, boasting an impressive impact factor that underscores its significance in the academic community. Spanning from 1985 to 2024, this journal not only disseminates high-quality research but also serves as a critical resource for healthcare professionals, researchers, and students alike who are focused on addressing the global diabetes epidemic. With its comprehensive scope and commitment to fostering innovative findings, DIABETES RESEARCH AND CLINICAL PRACTICE remains at the forefront of its field, fostering collaboration and discovery to improve patient outcomes.

Journal of Endocrinology Metabolism and Diabetes of South Africa, published by Routledge Journals, Taylor & Francis Ltd, serves as a vital platform for advancing research and knowledge dissemination in the fields of endocrinology, metabolism, and diabetes. Since its transition to Open Access in 2012, it has enabled greater accessibility to crucial findings and data, broadening its reach to researchers, practitioners, and students alike. Though its coverage in Scopus was discontinued in 2018, the journal continues to play an important role in fostering discourse in the medical community, as evidenced by its ranking within the 19th and 16th percentiles for Internal Medicine and Endocrinology, diabetes and metabolism, respectively. With its commitment to addressing pressing health issues in South Africa and beyond, this journal remains an invaluable resource for those seeking to understand and tackle the complexities of metabolic diseases.